SBIR Phase II Bridge Award
NEW: SBIR Phase II Bridge Award Funding Available
RFA-CA-10-009: SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44)
Application receipt date: March 1, 2010
Letter of Intent receipt date: February 1, 2010*
*Letter of Intent is not required
The SBIR Phase II Bridge Award is designed to support the next stage of development for previously funded NIH-wide SBIR Phase II projects in the areas of cancer therapies, diagnostics, and cancer imaging technologies. The purpose of this award is to address the funding gap known as the “Valley of Death” between the end of the SBIR Phase II award and the subsequent round of financing needed to advance a product or service toward commercialization.
To achieve this goal, the Bridge Award funding opportunity more than triples the amount of funding available to applicants through the NCI SBIR Program and incentivizes the development of partnerships between NIH’s SBIR Phase II awardees and third-party investors and/or strategic partners. Competitive preference and funding priority will be given to applicants that demonstrate the ability to secure substantial independent third-party investor funds (i.e., third-party funds that equal or exceed the requested NCI funds).
Budgets up to $1 million in total costs per year and project periods up to three years (a total of $3 million over three years) may be requested from the National Cancer Institute. Development efforts may include preclinical R&D, which is needed for regulatory filings (e.g., IND or IDE) and/or clinical trials. NCI intends to commit up to $10 million in fiscal year 2010. This funding opportunity is open to current and recently expired NIH SBIR Phase II projects.
Eligibility
The Bridge Award funding opportunity is open to current and recently expired NIH SBIR Phase II projects. Current awardees must be in the final year of their Phase II project period to apply. In general, past Phase II projects should have ended within 24 months of the application receipt date. The NCI will consider longer periods of hiatus on a case-by-case basis.
Prospective applicants are asked to submit a Letter of Intent (to apply) by February 1, 2010. Letter of Intent is suggested, but not required.
For information on where to send a Letter of Intent and how to apply to this funding announcement, visit http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-10-009.html.
Current SBIR Phase II Bridge Awardees
To learn about all current Bridge Awardees and the cancer technologies they are developing, click here to read NCI SBIR Bridge Award success stories.
Check back regularly for updates.
You may also sign up to receive email updates from the NCI SBIR & STTR Program announcing new funding opportunities. If you would like to receive updates from the NCI SBIR and STTR Program, please click here and provide the requested information.
Past SBIR Phase II Bridge Award Opportunities
RFA-CA-08-021: SBIR Phase II Bridge Awards to Accelerate the Development of New Cancer Therapies and Cancer Imaging Technologies Toward Commercialization (SBIR [R44])
Receipt Dates: September 19, 2008; February 27, 2009
